i
Preventing Cryptococcosis—Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy
-
2015
Source: Curr Trop Med Rep. 2(2):81-89. -
Alternative Title:Curr Trop Med Rep
-
Publisher's site:
-
Personal Author:
-
Description:Cryptococcosis remains a significant cause of morbidity and mortality among HIV-infected patients, especially in sub-Saharan Africa where it causes up to 20 % of AIDS-related deaths in HIV programs. A new, highly sensitive, and affordable point of care diagnostic test for cryptococcal infection, the lateral flow assay, can detect early sub-clinical cryptococcosis especially in areas with limited laboratory infrastructure. With a prevalence of detectable sub-clinical cryptococcal infection averaging 7.2 % (95 % CI 6.8-7.6 %) among 36 cohorts with CD4 <100 cells/μL in Africa, together with data showing that preemptive fluconazole prevents overt cryptococcal disease in this population, implementing a screen and treat strategy as part of HIV care practice among patients with CD4 <100 cells/μL could prevent the incidence of often fatal cryptococcal meningitis in the setting of the HIV pandemic.
-
Subject:
-
Source:
-
Pubmed ID:25960942
-
Pubmed Central ID:PMC4412515
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
[PDF-261.55 KB]
Email
CDC-INFO
